BAOS will endeavour to advertise any Oral Surgery vacancies it hears about on this page.
BAOS has no direct connection with any of these advertised positions and offers no endorsement or recommendation for the positions.
Please contact the Job advertisers/administrators directly for any further information or registration, please do not contact the BAOS administration team.
Competition Funded PhD Project, The molecular mechanisms underlying the tumour-determined immune cell infiltrate in oral squamous cell carcinoma
About the Project
Background and significance:Oral squamous cell carcinoma (OSCC) is one of the top ten cancers worldwide, with over 300,000 cases annually, and incidence is increasing both worldwide and in the UK (in the UK, incidence has increased by 23% over the past decade). The majority of cases are HPV-negative. HPV-negative OSCC is a deadly disease with frequent metastatic spread, which is the single most important predictor of outcome (1). It is also exceptionally amenable to in vitro experimental modelling of human tumour behaviour. This is due to the excellent recapitulation of in vivo tumour heterogeneity by established OSCC cell lines (2, 3). Tumours are infiltrated by an array of different cell types that interact with the tumour and greatly influence tumour behaviour and disease course (4). In HPV-negative OSCC, an important category of tumour infiltrating cells is the immune cell infiltrate, which contains an abundance of macrophages and T-cells (5). The makeup of the immune cell infiltrate has a marked impact on clinical outcome (6). Tumour infiltrating T-cells are a particular indicator of favourable prognosis in OSCC (7), whereas tumour associated macrophages (TAMs) are an indicator of poor prognosis (8). TAMs act to suppress T-cells, and therefore the makeup of the immune cell infiltrate has a major bearing on the response to immunotherapy techniques that seek to enhance the T-cell response to the tumour (9, 10). The makeup of the immune cell infiltrate is controlled by factors released by the tumour, and in this way each tumour determines its own immune cell infiltrate (9, 11). This raises the prospect that genetic and cellular profiling of the tumour may enable prediction of the immune cell infiltrate and thus selection of the best immunotherapeutic approach for the patient. Cancer stem cells (CSCs), the sub-population of tumour cells that possess tumour-initiating potential (12, 13), adopt phenotypes that drive tumour invasion and metastasis (14, 15) and express heightened resistance to therapy (2, 16). These cells are therefore of particular importance to tumour progression, and present a promising target for development of drugs that can stop metastasis. We have recently modelled the central role of CSCs in progression of OSCC (3, 14). In animal models of SCC, it has now been shown that CSCs interact with the immune infiltrate in order to create a permissive microenvironment that sustains their CSC phenotype and promotes tumour progression (17). This work now needs to be brought into a clinically relevant human OSCC model; understanding these interactions in human tumours may enable development of immunotherapeutic approaches that halt tumour progression by targeting the interactions between immune cells and CSCs.
Hypothesis and aims:We hypothesise that the mutational profile of the tumour generates heterogeneity between patients in tumour-immune interactions, which are mediated by CSCs. This plays an important role in determining the cellular profile of the immune infiltrate in OSCC, which influences tumour progression. We propose to test this hypothesis through the following aims: (a) Characterise the genetic drivers and the immune infiltrate in a retrospective cohort of FFPE OSCC specimens stratified by pathological prognosis, identifying associations between genetic drivers, immune components, and prognosis. (b) Test heterocellular interactions between defined tumour and immune cell populations in a tumour-on-a-chip device. (c) Assess the role of CSCs in mediating these interactions, and identify the key signalling molecules. Determine how these signalling molecules contribute mechanistically to the maintenance of CSCs and formation of the immune cell infiltrate.
Environment and supervision:This project will benefit from the state of the art facilities of the Blizard Institute, which have been created and funded to support cutting-edge multi-disciplinary research (www.qmul.ac.uk/blizard/research/core-facilities/). We have assembled an experienced multi-disciplinary team to manage this project. The project will be led by two OSCC experts (Dr Adrian Biddle, Blizard Institute; Dr Muy-Teck Teh, Institute of Dentistry) (2, 3, 14, 19, 20) and a head and neck pathologist (Dr Hannah Cottom, Barts Health) (3, 21, 22). The successful candidate must be a registered dental clinician in the UK.
Endodontist and Oral Surgeon, Ireland
Specialty Doctor in Oral Surgery
Job Reference: 326-SDORAL-02-PN
- Surrey and Sussex Healthcare NHS Trust
- Dental Services
- Redhill, Surrey
- £41,158 to £76,751 per annum
- The Care Quality Commission (CQC) has given us an outstanding rating
- SASH are in the top 20% nationally for staff recommending the Trust as a place to work or receive treatment
- Our workforce are amongst the most motivated in the country; SASH is well above the national average for overall staff engagement
- We are one of the safest hospitals in the country according to CQC’s intelligent monitoring
- Up to 96% of people surveyed would recommend us to their friends and family
- We are a National Patient Safety Awards Winner
- SASH has one of the lowest levels of nursing vacancies in the country
- Part time position
- Special interests considered
- Private Earnings: 50%
- Start date: We can be flexible for the right candidate.
- Duration: Permanent
- GDC Registration
- Hep B
- Indemnity Insurance
Oral Surgery dentist
Oral Surgeon - London Docklands
- Competitive UDA rate
- Excellent private potential
- Minimum of 3 years post qualification required.
- Easily commutable on public transport
- days/week negotiable
- 7 surgery top-spec practice, bright and modern